Benchmark Reiterates Buy on Ultralife, Maintains $12 Price Target
Portfolio Pulse from richadhand@benzinga.com
Benchmark analyst Josh Sullivan has reiterated a 'Buy' rating on Ultralife (NASDAQ:ULBI) and maintained a price target of $12.
August 08, 2023 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Josh Sullivan has reiterated a 'Buy' rating on Ultralife and maintained a price target of $12.
The reiteration of a 'Buy' rating by a Benchmark analyst and the maintenance of a $12 price target indicates a positive outlook for Ultralife. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100